Evidence map›Paper›PMID 39844357›Full record

ReviewClinical and translational science2025

Clinical Research Network: JHCRN Infrastructure and Lessons Learned.

Rahul Kashyap, Gayane Yenokyan, Robert Joyner, Melissa Gerstenhaber, Mary Alderfer, Erika Siegrist, Joan Moore, Channing J Paller, Hanan Aboumatar, James J Potter and 4 more

Abstract readReview
In one paragraph

Review in Clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rahul KashyapJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.ORCID 0000-0002-4383-3411
Gayane YenokyanJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
Robert JoynerJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.ORCID 0000-0002-7228-2671
Melissa GerstenhaberJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
Mary AlderferJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
Erika SiegristJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
Joan MooreJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
Channing J PallerJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
Hanan AboumatarJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
James J PotterJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.ORCID 0000-0002-1558-3945
Stanley WatkinsJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
John E NiederhuberJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
Daniel E FordJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.
Adrian DobsJohns Hopkins Clinical Research Network, Baltimore, Maryland, USA.

Funding

QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
Johns Hopkins Clinical Research Network (JHCRN)National Institute of Health (NIH)NCATS NIH HHS UL1 TR003098NIH Roadmap for Medical Research
6 · The paper itself

Abstract

Clinical research studies are becoming increasingly complex resulting in compounded work burden and longer study cycle times, each fueling runaway costs. The impact of protocol complexity often results in inadequate recruitment and insufficient sample sizes, which challenges validity and generalizability. Understanding the need to provide an alternative model to engage researchers and sponsors and bringing clinical research opportunities to the broader community, clinical research networks (CRN) have been proposed and initiated in the United States and other parts of the world. We report on the Johns Hopkins Clinical Research Network (JHCRN), established in 2009 as a multi-disease research collaboration between the academic medical centers and community hospitals/health systems. We have discussed vision, governance, infrastructure, participating hospitals' characteristics, and lessons learned in creating this partnership. Designed to leverage organized patient communities, community-based investigators, and academic researchers, the JHCRN provides expedited research across nine health systems in the mid-Atlantic region. With one IRB of record, a centralized contracting office, and a pool of dedicated network coordinators, it facilitates research partnerships to expand research collaborations among the differing sizes and types of hospitals/health systems in a region. As of August 2024, total 81 studies-clinical trials, cohort studies, and comparative effectiveness research have been conducted, with funding from the NIH, private foundations, and industry. The JHCRN experience has enhanced understanding of the complexity of participating sites and associated ambulatory practices. In conclusion, the CRN, as an academic-community partnership, provides an infrastructure for multiple disease studies, shared risk, and increased investigator and volunteer engagement.

Indexed as

Academic Medical CentersBiomedical ResearchCooperative BehaviorHospitals, CommunityHumansUnited Statesclinical research networkcollaborationinfrastructureinvestigators

Identifiers

PMID39844357
PMCPMC11754071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.